In practice, a curated variant database relevant for chemotherapy and other cancer therapy with established pharmacogenomic associations, such as gastrointestinal and bone marrow toxicity in carriers of the UGT1A1*28polymorphism, should be prioritized during routine germline analysis unless otherwise requested by the case clinician (29). This evidence concerns the gene UGT1A1 and cancer.